earnings
confidence high
sentiment positive
materiality 0.75
Exagen Q3 revenue $17.2M (+38% YoY), record; net loss $7.1M; guides FY rev $65-70M
EXAGEN INC.
2025-Q3 EPS reported
-$0.73
revenue$49,944,000
- Revenue $17.2M up 38% YoY; net loss $7.1M vs $5.0M loss last year.
- Adjusted EBITDA loss narrowed to $1.9M from $4.0M; gross margin improved to 58.4%.
- AVISE CTD test volume up 16% YoY; ASP $441 (+$37 YoY).
- Cash at $35.7M, up from $30.0M in Q2 2025.
- FY2025 revenue guidance $65-70M; expects positive adjusted EBITDA in Q4 at high end.